Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Spartacus Acquisition Corp. II sold 23 million units at $10 apiece, raising $230 million after exercising a 3 million unit overallotment. Units started trading on the NASDAQ Capital Market on February 11, 2026 under the symbol TMTSU. Proceeds were placed in a trust account and the company said it will pursue mergers or acquisitions focused on techn…
US Foods Inc., operating as US Foods-Lexington in South Carolina, has been awarded a $603,075,000 indefinite-delivery/indefinite-quantity contract by the Defense Logistics Agency Troop Support in Philadelphia to supply full-line food and beverage items to U.S. military services. The fixed-price agreement includes economic-price-adjustment provision…
TD Cowen has resumed coverage of XOMA, Ltd. with a Hold rating after the company's acquisition of Generation Bio. The firm highlighted XOMA's sizable royalty portfolio and robust recent revenue growth, while noting it needs more confidence in the revenue prospects and asset valuation before moving to a more positive rating. XOMA's balance sheet str…
U.S. officials have signed a finalized reciprocal trade pact with Taiwan that establishes a 15% U.S. tariff on Taiwanese imports and binds Taiwan to a timetable for cutting or removing tariffs on most U.S. goods. The agreement includes specific purchase commitments for 2025-2029 across energy, aerospace, power equipment and heavy industry, and imme…
Expedia projected 2026 gross bookings and revenue above Wall Street expectations, citing robust demand from business customers and increased participation by travel agencies and partners. The Vrbo-parent forecast gross bookings of $127 billion to $129 billion and revenue of $15.6 billion to $16 billion, while fourth-quarter adjusted profit and reve…
Newly released Justice Department records include a February 1, 2016 email from Dr. Mehmet Oz and his wife inviting Jeffrey Epstein to a Valentine’s Day event. The files, published to comply with bipartisan congressional legislation, disclose multiple references to Oz in Epstein-related documents. Oz is not accused of wrongdoing in connection with …
DA Davidson initiated coverage of Intel Corporation (INTC) assigning a Neutral rating and a $45.00 price target. The firm's view highlights a major operational reset underway at Intel and recognizes tangible business developments that have driven substantial recent share gains, while warning that current market expectations embedded in the stock ap…
DA Davidson began coverage of Taiwan Semiconductor Manufacturing Company (TSMC) with a Buy rating and a $450.00 price objective, pointing to the company's established manufacturing execution and recent technology milestones as key advantages. The firm highlighted TSMC's financial strength, strong margins and the commercialization of its N2 node, wh…
Goldman Sachs shifted its rating on Copa Holdings (NYSE:CPA) from Buy to Neutral, while modestly raising its price target to $151 from $150. The bank cited limited upside for further re-rating despite recognizing the Panama-based carrier's strong operational performance and improving fundamentals. Recent financial results and competing analyst view…
Goldman Sachs downgraded LATAM Airlines Group (NYSE: LTM) from Buy to Neutral and reduced its price target to $64.10 from $66.20, pointing to constrained upside following a substantial share-price rally since October 2024. The firm retained its Q5-Q8 EV/EBITDA target multiple at 5.0x but revised forecasts, producing a price target that implies mini…
PTC Therapeutics said it has withdrawn its resubmitted New Drug Application for Translarna, a therapy for nonsense mutation Duchenne muscular dystrophy, after the U.S. Food and Drug Administration indicated the data were unlikely to meet the agency's threshold for substantial evidence of effectiveness. The announcement coincided with a roughly 4% d…
Arhaus has pulled back to $9.13 after a bout of selling that looks more technical than structural. The business is cash-generative, lightly levered, and expanding showrooms while raising revenue guidance in recent quarters. At roughly $1.29B market cap and a P/S near 1.0, this is a buy-the-dip setup with a clear entry, stop, and target for a mid-te…
U.S.-controlled oil shipments from Venezuela have generated more than $1 billion to date and are expected to produce an additional $5 billion over the next few months, U.S. Secretary of Energy Chris Wright said in an interview. Much of the crude is being refined at U.S. facilities and the proceeds have been transferred to Venezuela's interim govern…
Columbus Circle Capital Corp. II completed an initial public offering that generated $230 million through the sale of 23 million units at $10 each, including the full exercise of a 3 million-unit over-allotment. Units began trading on the NASDAQ Global Market as CMIIU on February 11, 2026, and the offering proceeds alongside a concurrent private pl…
Columbus Circle Capital Corp. II completed an initial public offering of 23 million units at $10 apiece, collecting $230 million in proceeds that were placed in a trust account for public shareholders. The units, which include a Class A ordinary share and one-third of a redeemable warrant, began trading on the Nasdaq Global Market on February 11, 2…
DA Davidson has initiated coverage of Advanced Micro Devices (AMD) with a Neutral rating and a $220 price target, noting the company’s strong CPU market positions and 34.34% year-over-year revenue growth to $34.64 billion, while characterizing AMD as a "marginal AI accelerator player" facing scale-related integration and utilization challenges in A…
Stifel reduced its 12-month price objective for Tyler Technologies (TYL) to $400 from $550 while keeping a Buy rating, pointing to the company's movement toward a subscription-heavy, software-as-a-service model. The downgrade arrives as the shares have fallen more than 44% over the past year and trade close to a 52-week low. Stifel highlighted the …
DA Davidson opened coverage of Broadcom Limited (AVGO) with a Neutral rating and a $335 price target, citing doubts about the long-term sustainability of Broadcom's position in the AI application-specific integrated circuit (ASIC) market. The firm acknowledged Broadcom's high gross margins and notable revenue growth but warned that large customers …
A New York Fed official said the central bank will keep sizable Treasury bill and short-term government bond purchases in place through mid-April to rebuild reserves and manage liquidity around the annual tax filing date. The purchases, described as technical reserve management operations, total about $40 billion per month and sit alongside other g…
Preliminary Brazilian census bureau data show a sharp uplift in cattle slaughtering in Q4, up 13.1% year-over-year, and point to a potential record 42.3 million head processed in 2025. Robust Chinese purchases are cited as the primary driver, but recent Chinese safeguard measures and quota rules introduce near-term trade uncertainty for Brazilian p…
Freedom Capital Markets upgraded Gilat Satellite Networks (NASDAQ:GILT) from Hold to Buy and lifted its price target to $18.00 from $17.00 after what it described as impressive fourth-quarter 2025 results that significantly beat market expectations for revenue and EPS. The firm pointed to In-Flight Connectivity momentum, accelerated Peru project de…
Sanofi's board removed CEO Paul Hudson effective 02/17/2026 and named Belén Garijo as incoming CEO on 04/29/2026. The stock has pulled back to $47.03 after the news but trades at a market cap of $113.95B with a P/E of 13.63 and a 3.25% dividend yield. We view the sell-off as an overreaction and recommend a mid-term long with exact entry, stop and t…
Freedom Capital Markets cut Amgen's rating to Hold from Buy while nudging its 12-month price objective up to $375 from $360. The move reflects the firm's view that shares are approaching fair value even after Amgen posted stronger-than-expected fourth-quarter results and upward guidance for 2026. Analysts across the street issued mixed target chang…
Freedom Capital Markets cut its recommendation on BP from Hold to Sell while keeping a $37.00 price target. The downgrade follows Q4 2025 results described as soft but broadly in line with expectations, and comes amid a suspension of the company’s share repurchase program and concerns that further oil price weakness in 2026 could materially pressur…
A batch of corporate updates triggered notable after-hours moves across sectors. Applied Materials surged after delivering stronger-than-expected quarterly results and upbeat guidance. A mix of beats and misses followed across chip equipment, streaming, electric vehicles, online marketplaces, and gaming, with several companies upping forward views …
